MILOSO MARIAROSARIA
- U08, Floor: 1, Room: 1030
Publications
Cavalloro, V., Marchesi, N., Linciano, P., Rossi, D., Campagnoli, L., Fossati, A., et al. (2024). Neurodegeneration: can metabolites from Eremurus persicus help?. FRONTIERS IN PHARMACOLOGY, 15, 1-13 [10.3389/fphar.2024.1309766]. Detail
Malacrida, A., Deschamps-Wright, M., Rigolio, R., Cavaletti, G., Miloso, M. (2023). Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(2) [10.3390/ijms24021721]. Detail
Malacrida, A., Erriquez, J., Hashemi, M., Rodriguez-Menendez, V., Cassetti, A., Cavaletti, G., et al. (2022). Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells. BIOCHEMISTRY AND BIOPHYSICS REPORTS, 32(December 2022) [10.1016/j.bbrep.2022.101353]. Detail
Listro, R., Malacrida, A., Ambrosio, F., Rossino, G., Di Giacomo, M., Cavalloro, V., et al. (2022). From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(21) [10.3390/ijms232113061]. Detail
Malacrida, A., Cavaletti, G., Miloso, M. (2022). Rigosertib and cholangiocarcinoma: A cell cycle affair. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(1) [10.3390/ijms23010213]. Detail